Profile
Timothy E.
Cloutier worked as a Director of Commercialization Operations at Illumina, Inc. from 2013 to 2016.
He then worked as a Director of Strategic Marketing at Biora Therapeutics, Inc. from 2016 to 2019.
From 2019 to 2020, he served as Vice President of Marketing & Portfolio Strategy at BioLegend, Inc. In 2020, he became Senior Vice President of Commercial Operations at Telesis Bio, Inc. Prior to his career, he earned an undergraduate degree from Michigan State University and a doctorate from Albert Einstein College of Medicine, Inc.
Former positions of Timothy E. Cloutier
| Companies | Position | End |
|---|---|---|
| TELESIS BIO, INC. | Corporate Officer/Principal | 2021-09-16 |
BioLegend, Inc.
 BioLegend, Inc. BiotechnologyHealth Technology BioLegend, Inc. develops and manufactures cutting edge immunological reagents for biomedical research. It offers mouse immunology, human immunology, rat immunology, non-human primate immunology, cell biology, direct-blot, secondary reagents, recombinant proteins, cytokines chemokines and factors, immunoassays, neuroscience, cell separation, soluble MHC, cell health, cellular dyes and ancillary products, diagnostics, and lyophilized control cells. The company was founded by Gene Lay in 2002 and is headquartered in San Diego, CA. | Sales & Marketing | 2020-07-31 |
| BIORA THERAPEUTICS, INC. | Corporate Officer/Principal | 2019-03-31 |
| ILLUMINA, INC. | Corporate Officer/Principal | 2016-04-30 |
Training of Timothy E. Cloutier
| Michigan State University | Undergraduate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| TELESIS BIO, INC. | Commercial Services |
| BIORA THERAPEUTICS, INC. | Health Services |
| Private companies | 1 |
|---|---|
BioLegend, Inc.
BioLegend, Inc. BiotechnologyHealth Technology BioLegend, Inc. develops and manufactures cutting edge immunological reagents for biomedical research. It offers mouse immunology, human immunology, rat immunology, non-human primate immunology, cell biology, direct-blot, secondary reagents, recombinant proteins, cytokines chemokines and factors, immunoassays, neuroscience, cell separation, soluble MHC, cell health, cellular dyes and ancillary products, diagnostics, and lyophilized control cells. The company was founded by Gene Lay in 2002 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Timothy E. Cloutier
